- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
- Volume is elevated versus the 13-week average, confirming attention.
2395
JPX
Week ended 07 Aug 2026
Weekly Investor Report
Shin Nippon Biomedical Laboratories, Ltd. · Healthcare · Diagnostics & Research
Latest close
1,470 JPY
15.1%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 4.7% above the Trend Line and sits at 44.3% of its 52-week range. The latest completed week returned 15.1%, after a 15.3% four-week move. The latest news-sentiment score is 50/100.
Setup score
44
out of 100
Latest Close
1,470 JPY
7 Aug 2026
1W Return
15.1%
latest completed week
4W Return
15.3%
short-term follow-through
12W Return
20.5%
quarterly tape
Trend Breadth
50.0%
26 of 52 weeks active
Volume Ratio
2.1x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Next-week expectancy is negative at 44.55% based on similar historical setup states.
- Activity pressure is weak, so confirmation is not yet broad enough.
- The share remains more than 20% below its 52-week high.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
15.1%
Latest completed week; four-week move 15.3%.
Indicator stack
28/72
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 44.55%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
3 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 4.7% above the Trend Line and sits at 44.3% of its 52-week range. The latest completed week returned 15.1%, after a 15.3% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 2.1x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0912-week average 0.09
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure2/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.09Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 15.3% over four weeks, 20.5% over 12 weeks, and 5.6% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year26
Trend breadth50.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.51Latest activity-pressure read.
Pressure change162.9%Four-week change in activity pressure.
Leadership-20.37Latest relative-leadership reading.
RS change43.6%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 3 relevant articles.
0 positive · 3 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-25.1%Distance below the 52-week high.
13-week volatility7.2%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher12 of 2614 weeks finished lower.
Best week+15.1%Week of 7 Aug.
Worst week-15.0%Week of 15 May.
Latest week+15.1%Week of 7 Aug.
Shape of recent returns
Strong gains5
Modest gains7
Flat weeks0
Modest losses9
Sharp losses5
Recent vol7.2%13-week weekly-return volatility.
Base vol5.0%52-week weekly-return volatility.
Up/down split24/28Count of positive and negative weeks in the 52-week window.
Average skew4.2% / -3.2%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorJP Healthcare
4-week rank4 / 100
Group average1.7%
Trend breadth29.0%
Trend29.0%active weekly trend signals
MD56.0%positive activity pressure
RS13.0%positive relative leadership
Four-week leaders
IndustryJP Diagnostics & Research
4-week rank1 / 6
Group average2.5%
Trend breadth16.7%
Trend16.7%active weekly trend signals
MD66.7%positive activity pressure
RS0.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape35/100
Trend, activity pressure, participation, and risk combine to a 35/100 tape read.
Indicator analysis13/100Latest 12-week confirmation: trend 0/12, activity pressure 2/12, relative leadership 0/12.
Activity pressure 0.09; No reversal markers Next-Week ExpectancyNegative 44.55%Next-week expectancy is negative with a 44.55% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 3 relevant articles.
ETFs Investing in Shin Nippon Biomedical Laboratories, Ltd. Stocks Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 1,470 JPY | 15.1% | 1,403 JPY | 1,442 JPY | 0.51 | -20.37 | 2.3M | Off |
| 31 Jul 2026 | 1,277 JPY | 0.1% | 1,408 JPY | 1,446 JPY | 0.17 | -30.01 | 1.0M | Off |
| 24 Jul 2026 | 1,276 JPY | -0.2% | 1,420 JPY | 1,452 JPY | -0.19 | -30.96 | 550.6K | Off |
| 17 Jul 2026 | 1,279 JPY | 0.3% | 1,434 JPY | 1,455 JPY | -0.49 | -30.90 | 1.5M | Off |
| 10 Jul 2026 | 1,275 JPY | 9.0% | 1,453 JPY | 1,459 JPY | -0.81 | -36.12 | 1.3M | Off |
| 3 Jul 2026 | 1,170 JPY | 4.7% | 1,472 JPY | 1,462 JPY | -1.12 | -42.95 | 128.3K | Off |
| 26 Jun 2026 | 1,117 JPY | 3.0% | 1,492 JPY | 1,467 JPY | -1.22 | -45.88 | 146.5K | Off |
| 19 Jun 2026 | 1,084 JPY | -0.1% | 1,514 JPY | 1,472 JPY | -1.22 | -49.43 | 121.0K | Off |
| 12 Jun 2026 | 1,085 JPY | -3.4% | 1,534 JPY | 1,478 JPY | -1.16 | -46.05 | 161.3K | Off |
| 5 Jun 2026 | 1,123 JPY | -7.7% | 1,549 JPY | 1,484 JPY | -1.07 | -45.25 | 189.8K | Off |
| 29 May 2026 | 1,217 JPY | -4.9% | 1,560 JPY | 1,489 JPY | -1.02 | -41.03 | 1.0M | Off |
| 22 May 2026 | 1,280 JPY | 4.9% | 1,567 JPY | 1,495 JPY | -1.04 | -35.70 | 1.7M | Off |
| 15 May 2026 | 1,220 JPY | -15.0% | 1,574 JPY | 1,500 JPY | -1.05 | -37.28 | 3.7M | Off |
| 8 May 2026 | 1,435 JPY | 1.8% | 1,585 JPY | 1,505 JPY | -1.07 | -28.36 | 842.4K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.